Cargando…
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung squamous cell carcinoma (LSCC) have not benefitted from targeted therapies. Although immunotherapy has significantly improved cancer patients’ outcomes, the relatively low respon...
Autores principales: | Niu, Zhenyi, Jin, Runsen, Zhang, Yan, Li, Hecheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535022/ https://www.ncbi.nlm.nih.gov/pubmed/36198685 http://dx.doi.org/10.1038/s41392-022-01200-x |
Ejemplares similares
-
Three-dimensional computed tomography reconstruction in video-assisted thoracoscopic segmentectomy (DRIVATS): A prospective, multicenter randomized controlled trial
por: Niu, Zhenyi, et al.
Publicado: (2022) -
Primary small cell carcinoma of the esophagus: progression in the last decade
por: Ji, Anqi, et al.
Publicado: (2020) -
Comment on “The Unbearable Lightness of Difference Between Statistical and Clinical Significance”
por: Cao, Yuqin, et al.
Publicado: (2022) -
Interactions between the enhanced recovery after surgery pathway and risk factors for lung infections after pulmonary malignancy operation
por: Zhang, Xianfei, et al.
Publicado: (2020) -
Clusterin modulates transdifferentiation of non-small-cell lung cancer
por: Jin, Runsen, et al.
Publicado: (2017)